Recurrent Solid Neoplasm Recruiting Phase 1 Trials for Trametinib (DB08911)

IndicationStatusPhase
DBCOND0080814 (Recurrent Solid Neoplasm)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs